Radiation-induced Esophagitis Market Trends 2030

1. DELVEINSIGHT BUSINESS RESEARCH 2020 The Market Research of radiation-induced esophagitis (RIE) is expected to increase in 2030 Radiation-induced Esophagitis market Radiation-induced Esophagitis and painful swallowing (odynophagia) are common and debilitating treatment toxicities for patients undergoing radiotherapy for lung, breast, or head and neck cancers or lymphoma, and represent a significant clinical and research challenge released by Radiation-induced Esophagitis market Recent advances in radiographic quantification of esophagitis grade and the identification of candidate predictive biomarkers and multivariate risk-stratification models might lead to more timely detection and management of esophageal radiotoxicities. But the optimal dosimetric strategy for preventing radiation esophagitis has yet to be identified. Several clinical trials are under way to test potential treatments. Acute radiotherapy-induced esophagitis (ARIE) is the most frequent local complication of thoracic radiotherapy; it is debilitating and can cause treatment disruptions and treatment discontinuation, affecting both patients’ quality of life and prognosis.1-4Radiotherapy-induced mucosal inflammation, epithelial ulceration, and spikes in inflammatory cytokines are suspected pathophysiological culprits by Radiation-induced Esophagitis market report

2. DELVEINSIGHT BUSINESS RESEARCH 2020 Higher radiation dose and combined chemo radiation are both associated with the risk of developing esophagitis and painful swallowing (odynophagia).1-3Some patients develop late esophageal stricture, with similar symptoms — but these cases are more frequently irreversible.3. In general, Radiation-induced Esophagitis market disease occurs within 3 months after completion of radiotherapy; however, typically onset occurs 2 weeks after treatment begins and lasts until 4 weeks after treatment concludes, with progressively worsening odynophagia, nausea, dysphagia, and, if ineffectively managed, anorexia.1, 3. Late radiation esophagitis occurs more than 3 months after radiotherapy ends, with an average time from treatment to symptom onset of 6 months. Radiation esophagitis ranges from asymptomatic or mild fibrosis and slight difficulty with swallowing solid food to severe ulceration, fibrosis, perforation, necrosis, and even fistula.2, 3Severity is graded on a scale of 1 to 5: grade 1 represents clinically or radio graphically detected and asymptomatic; grade 2 and 3, symptomatic with altered eating habits; grade 4, life-threatening requiring invasive intervention; and 5, patient death Source:- Radiation-induced Esophagitis market research